Insilico Medicine and Tenacia Biotechnology Collaborate for CNS Innovations Worth Up to $94.75 Million Insilico Medicine and Tenacia Biotechnology have expanded their partnership to enhance AI-driven CNS therapies, with potential deal value maxing at $94.75 million.

Insilico Medicine and Tenacia Biotechnology Collaborate for CNS Innovations Worth Up to $94.75 Million #United_States #Cambridge #Insilico_Medicine #CNS_therapies #Tenacia_Biotechnology

EQT Foundation Launches Science Grants for Breakthrough CNS Drug Delivery Innovations The EQT Foundation has unveiled its latest Science Grants program, inviting proposals for innovative solutions to overcome the blood-brain barrier in CNS therapies.

EQT Foundation Launches Science Grants for Breakthrough CNS Drug Delivery Innovations #Sweden #Stockholm #EQT_Foundation #CNS_therapies #blood-brain_barrier